Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and...
–Company to host conference call to discuss positive Phase 2 CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET – – Complete Phase 2...
Christian Antoni Montai Health has kept most of its business under wraps since emerging from stealth last December. But this week the startup hired its...
– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated...
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the United States Patent and Trademark Office has issued two patent grants that offer protection...
Cybin has added to this growing IP portfolio with the granting of two more patents for its DMT program. The post Cybin Granted Two New Patents...
–New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis – – Intellectual...
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement. Following their...
The Harvard Gazette announced that the venerable Ivy League University will create a Study of Psychedelics in Society and Culture with a multi-million...
Cybin Inc. (NYSE AMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...